<?xml version="1.0" encoding="UTF-8"?>
<p>Since the development of the 2019-nCoV epidemic, China has recommended RT-PCR technology as a guideline for the COVID-19 diagnosis and treatment program (
 <xref rid="b21-etm-0-0-09142" ref-type="bibr">21</xref>). The Chinese Center for Disease Control and Prevention recommends the use of primers and fluorescent probes (FAM, BHQ1 and TAMRA) targeting 2019-nCoV ORF1ab and nucleocapsid protein (N) gene regions (
 <xref rid="tI-etm-0-0-09142" ref-type="table">Table I</xref>) (
 <xref rid="b23-etm-0-0-09142" ref-type="bibr">23</xref>).
</p>
